In the last decade when the number of visceral leishmaniasis in immunocompromised patients has been increasing, our data presented herein offered a novel insight into the possibly involvement of CD4+Foxp3+ Tregs in persistent L. donovani infection in the liver of immunodeficient hosts. The gene discussed is FOXP3; the disease is visceral leishmaniasis.